Assignee
UROVANT SCIENCES GMBH
CH·2 granted patents·8 pending applications·1 citations·filing 2018–2025
Top patents by PatentIndex Score
10 records- 0170US12102638B2Use of vibegron to treat overactive bladderUROVANT SCIENCES GMBH·Filed 2018·Granted Oct 1, 2024·1 cites·54 claims
- 0257US2023218624A1Dosing of vibegron for treatment of overactive bladderUROVANT SCIENCES GMBH·Filed 2022·Application pending·0 cites
- 0354US12357636B2Vibegron for the treatment of overactive bladder symptomsUROVANT SCIENCES GMBH·Filed 2019·Granted Jul 15, 2025·0 cites·29 claims
- 0454US2024050457A1Methods of monitoring digoxin with concomitant use of vibegron to treat overactive bladderUROVANT SCIENCES GMBH·Filed 2021·Application pending·0 cites
- 0554US2026014158A1Use of vibegron to treat overactive bladderUROVANT SCIENCES GMBH·Filed 2025·Application pending·0 cites
- 0649US2024148735A1Methods of treating heart failure with vibegronUROVANT SCIENCES GMBH·Filed 2022·Application pending·0 cites
- 0744US2023027066A1Use of vibegron to treat overactive bladderUROVANT SCIENCES GMBH·Filed 2020·Application pending·0 cites
- 0842US2022133849A1Compositions and methods for the treatment of smooth muscle dysfunctionUROVANT SCIENCES GMBH·Filed 2019·Application pending·0 cites
- 0940US2021196720A1Use of vibegron to treat pain associated with irritable bowel syndromeUROVANT SCIENCES GMBH·Filed 2019·Application pending·0 cites
- 1037US2021077496A1Dosing of vibegron for treatment of overactive bladderUROVANT SCIENCES GMBH·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →